<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=348185225613720&amp;ev=PageView&amp;noscript=1">

Case Study.png

Rapid, Scalable, and Ultra-Sensitive Validation of Allele-Specific Gene Editing Events with genoTYPER-NEXTTM 

This case study focuses on a collaboration between GENEWIZ and a large pharmaceutical client to develop a more effective approach for screening engineered cell lines via an automated, interactive NGS-based platform. This powerful technology permits the identification of all classes of genetic disruptions, including mono-allelic, homozygous, and heterozygous biallelic modifications.

Download the Case Study

For technical support questions, please contact our NGS team

 (908) 222-0711 ext. 1 |  ngs@genewiz.com